Search hospitals > Texas > Houston
Ben Taub General Hospital
Claim this profileHouston, Texas 77030
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Leukemia
162 reported clinical trials
25 medical researchers
Summary
Ben Taub General Hospital is a medical facility located in Houston, Texas. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Prostate Cancer, Leukemia and other specialties. Ben Taub General Hospital is involved with conducting 162 clinical trials across 302 conditions. There are 25 research doctors associated with this hospital, such as Mothaffar Rimawi, MD, Ahmed Elkhanany, Quillan Huang, and Aihua E. Yen.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
ER positive
2Lung Cancer
Global LeaderStage II
Stage I
Stage III
Top PIs
Mothaffar Rimawi, MDBaylor College of Medicine5 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
23 drugs studied
Ahmed ElkhananyUniversity of Alabama at Birmingham Cancer Center1 year of reported clinical research
Studies Breast Cancer
Studies Breast cancer
10 reported clinical trials
24 drugs studied
Quillan HuangBaylor College of Medicine/Dan L Duncan Comprehensive Cancer Center3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
6 reported clinical trials
14 drugs studied
Aihua E. YenMichael E DeBakey VA Medical Center3 years of reported clinical research
Studies Cancer
Studies Bladder Cancer
6 reported clinical trials
31 drugs studied
Clinical Trials running at Ben Taub General Hospital
Breast Cancer
Lung Cancer
Breast cancer
Bladder Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Urothelial Carcinoma
Squamous Cell Carcinoma
Postoperative Pain
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Ben Taub General Hospital?
Ben Taub General Hospital is a medical facility located in Houston, Texas. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Prostate Cancer, Leukemia and other specialties. Ben Taub General Hospital is involved with conducting 162 clinical trials across 302 conditions. There are 25 research doctors associated with this hospital, such as Mothaffar Rimawi, MD, Ahmed Elkhanany, Quillan Huang, and Aihua E. Yen.